Tauro 6-ethlchenodeoxycholic acid-d5(sodium）
Product Specifications
UNSPSC Description
Tauro 6-ethlchenodeoxycholic acid-d5(sodium） is deuterium labeled Tauro-obeticholic acid. Tauro-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an orally bioavailable farnesoid-X receptor (FXR) agonist[1][2].
Target Antigen
FXR; Isotope-Labeled Compounds
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease;Others
Field of Research
Inflammation/Immunology
Smiles
OC1CC[C@]2([C@@]([H])(C1)[C@H]([C@H]([C@@]3([C@@]2(CC[C@]4([C@]3(CC[C@@]4([C@H](C)CCC(NCCS(=O)(O[Na])=O)=O)[H])[H])C)[H])[H])O)C([2H])(C([2H])([2H])[2H])[2H])C
Molecular Weight
554.77
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76(12):1221-6.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
